Sanofi flu vaccines licensed and approved for 2022-2023 influenza
https://www.news.sanofi.us/2022-07-01-Sanofi-flu-vaccines-licensed-and-approved-for-2022-2023-influenza-season,-including-CDC-preferred-higher-dose-vaccines-for-adults-65
WEBBRIDGEWATER, N.J., July 1, 2022 /PRNewswire/ -- Today the US Food and Drug Administration (FDA) approved Sanofi's licensure request for vaccine approval for the upcoming 2022-2023 flu season, including: Fluzone High-Dose Quadrivalent (Influenza Vaccine), Flublok Quadrivalent (Influenza Vaccine) and Fluzone Quadrivalent …
DA: 81 PA: 46 MOZ Rank: 72